Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7501 p556
10 May 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Users say summary care record is “too complex”

NHS CfH criticised

The Government’s Connecting for Health team was criticised by the researchers for focusing too much on the technology of the initiative, rather than looking at the wider picture and the benefits it could bring patients.

The report says: “A shift to a more socio-technical perspective would change the SCR programme considerably … it would no longer be seen as an end in itself (with ‘success’ measured in terms of number of records created and extent of use) but as a means to other ends (with success being defined in terms of a range of locally relevant ends).”

An independent evaluation of the patient summary care record (SCR) has reached mixed conclusions, according to its report published this week.
(PDF 2.1MB)

A team from University College London accepted at the end of a year-long study that having an SCR — a summary of a patient’s key medical details such as medication, allergies and known adverse reactions — on a central national electronic database was a particular advantage in emergency or unscheduled care settings.

It would also be useful in cases where patients did not have English as their first language, were unconscious or confused about their medical details.

Although the researchers reported that many staff in the four SCR early adopter sites studied were enthusiastic about the initiative, a significant number of GPs had refused to participate in the project because they were concerned about the quality of the data.

Other staff complained that the system was “clunky” and “too complex”, and some said they had given up using the SCR “until it works better”, they found.

Patients’ attitudes to their record varied according to their medical condition and were influenced by their personal trust and confidence in their primary health care team, says the report.

Most patients, especially those with a potentially stigmatising illness such as mental ill health or HIV, while supporting the idea of an SCR, were equally keen to control who had access to the information.

Gillian Braunold, clinical director of the summary care record and HealthSpace programme, said following publication of the report: “We set up the early adopter programme to ensure that problems, issues and practicalities of implementation were tested out in real-life healthcare situations in a controlled and safe environment.

“The report offers the programme the foundations on which to base the necessary planning for improvement in design and implementation before national roll out.”

In response to the evaluation, President of the Royal Pharmaceutical Society Hemant Patel said: “The widespread adoption of SCRs will assist our vision to make Britain the safest place to receive medicines.”

He added that pharmacists’ access to records will benefit patients and enhance joint working with GPs.

“[Pharmacist access] should also … help the Government meet its target of reducing by 40 per cent the number of serious errors in the use of prescribed drugs as well as helping reduce the human and financial cost of prescribing errors,” he said.

Back to Top


©The Pharmaceutical Journal